Moderna

Moderna, founded in 2010, has established itself as a trailblazer in the Biotechnology and Pharmaceutical industries, with a focus on developing mRNA medicines. The company's mission, "to deliver the greatest possible impact to people through mRNA medicines," highlights its dedication to transforming healthcare by innovating treatments for infectious diseases, cancer, and rare diseases.

With its headquarters in the United States, Moderna benefits from a robust technology platform and a global workforce that embodies the company's values and culture. The organization’s advancements have attracted significant interest, epitomized by a recent $176.00M grant investment from the U.S. Department of Health & Human Services on July 2, 2024.

This investment underscores confidence in Moderna's potential to innovate in health care, making it a compelling opportunity for investors seeking to support cutting-edge medical breakthroughs.